Daratumumab is effective in the relapsed or refractory systemic light‐chain amyloidosis but associated with high infection burden in a frail real‐life population
BRITISH JOURNAL OF HAEMATOLOGY(2020)
关键词
AL-Amyloidosis,daratumumab,frailty
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要